الصفحة الرئيسية>>Proteins>> Recombinant Proteins>> Superoxide Dismutase>>Cu-ATSM

Cu-ATSM (Synonyms: copper-ATSM, CuII(atsm))

رقم الكتالوجGC43329

Cu-ATSM هو أحد مضادات الأكسدة القوية للغاية التي تحبس الجذور (RTA) ومثبط لبيروكسيد الدهون (الفوسفو) ، وبالتالي يفسر قدرتها على تثبيط الإصابة بالفيروسات.

Products are for research use only. Not for human use. We do not sell to patients.

Cu-ATSM التركيب الكيميائي

Cas No.: 68341-09-3

الحجم السعر المخزون الكميّة
1mg
28٫00
متوفر
5mg
83٫00
متوفر
10mg
144٫00
متوفر
25mg
315٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

The metallo-protein Cu/Zn-superoxide dismutase (SOD1) is a ubiquitous enzyme responsible for scavenging superoxide radicals. Mutations in SOD1, which alter its metal binding capacity and can result in protein misfolding and aggregation, have been linked to familial amyotrophic lateral sclerosis (ALS). Cu-ATSM is an orally bioavailable, blood-brain barrier permeable complex that has traditionally been used in cellular imaging experiments to selectively label hypoxic tissue via its susceptibility to reduction by oxygen-depleted mitochondria. More recently, Cu-ATSM has been reported to improve locomotor function and survival in a transgenic ALS mouse model by delivering copper specifically to cells in the spinal cords of mice producing misfolded SOD1 proteins. Copper chaperone for SOD (CCS) is presumed to utilize the copper from Cu-ATSM to prevent misfolding of the SOD1 protein.

مراجعات

Review for Cu-ATSM

Average Rating: 5 ★★★★★ (Based on Reviews and 21 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Cu-ATSM

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.